Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Cardiogenic | 36 | 2025 | 213 | 6.810 |
Why?
|
| Myocardial Infarction | 17 | 2025 | 1063 | 3.120 |
Why?
|
| Heart Failure | 30 | 2025 | 2392 | 3.080 |
Why?
|
| Registries | 17 | 2025 | 1589 | 2.220 |
Why?
|
| Heart-Assist Devices | 15 | 2025 | 1084 | 2.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2025 | 659 | 1.720 |
Why?
|
| Heart Transplantation | 7 | 2023 | 875 | 1.510 |
Why?
|
| Hospital Mortality | 18 | 2025 | 1078 | 1.200 |
Why?
|
| Intra-Aortic Balloon Pumping | 4 | 2025 | 48 | 1.120 |
Why?
|
| Hemodynamics | 8 | 2024 | 864 | 0.880 |
Why?
|
| Ventricular Septal Rupture | 1 | 2021 | 3 | 0.740 |
Why?
|
| Myocarditis | 2 | 2020 | 131 | 0.700 |
Why?
|
| Endocarditis | 3 | 2018 | 108 | 0.660 |
Why?
|
| Coronary Disease | 1 | 2023 | 683 | 0.620 |
Why?
|
| Coronary Artery Disease | 2 | 2023 | 892 | 0.620 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 247 | 0.600 |
Why?
|
| Heart Diseases | 1 | 2023 | 511 | 0.590 |
Why?
|
| Propensity Score | 1 | 2019 | 255 | 0.580 |
Why?
|
| Heart Arrest | 1 | 2022 | 373 | 0.560 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 127 | 0.550 |
Why?
|
| Treatment Outcome | 13 | 2025 | 13017 | 0.540 |
Why?
|
| Middle Aged | 26 | 2025 | 28936 | 0.460 |
Why?
|
| Humans | 56 | 2025 | 132105 | 0.460 |
Why?
|
| Relaxin | 1 | 2013 | 15 | 0.420 |
Why?
|
| Aged | 21 | 2025 | 21413 | 0.410 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 208 | 0.370 |
Why?
|
| Machine Learning | 2 | 2025 | 347 | 0.360 |
Why?
|
| Male | 27 | 2025 | 64918 | 0.320 |
Why?
|
| Retrospective Studies | 15 | 2025 | 17374 | 0.290 |
Why?
|
| Female | 26 | 2025 | 70680 | 0.280 |
Why?
|
| Prognosis | 4 | 2025 | 5008 | 0.250 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2025 | 51 | 0.230 |
Why?
|
| Axillary Artery | 1 | 2025 | 31 | 0.230 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 558 | 0.230 |
Why?
|
| Femoral Artery | 1 | 2025 | 168 | 0.220 |
Why?
|
| International Cooperation | 1 | 2025 | 165 | 0.220 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 79 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2025 | 108 | 0.210 |
Why?
|
| Developing Countries | 1 | 2025 | 276 | 0.200 |
Why?
|
| Allografts | 1 | 2023 | 196 | 0.190 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2023 | 98 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 1246 | 0.190 |
Why?
|
| Survival Rate | 5 | 2025 | 2186 | 0.180 |
Why?
|
| Cardiotonic Agents | 1 | 2023 | 135 | 0.180 |
Why?
|
| Shock | 1 | 2022 | 99 | 0.180 |
Why?
|
| Patients | 1 | 2022 | 127 | 0.180 |
Why?
|
| Cardiac Catheterization | 2 | 2025 | 671 | 0.170 |
Why?
|
| Disease Management | 1 | 2025 | 564 | 0.170 |
Why?
|
| Ischemia | 1 | 2024 | 373 | 0.170 |
Why?
|
| Tertiary Care Centers | 2 | 2023 | 260 | 0.170 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2020 | 21 | 0.170 |
Why?
|
| Febrile Neutropenia | 1 | 2020 | 15 | 0.170 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 88 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 438 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 333 | 0.160 |
Why?
|
| Coronary Vessels | 1 | 2023 | 549 | 0.150 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 139 | 0.150 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2023 | 304 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2023 | 336 | 0.150 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2019 | 11 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 158 | 0.150 |
Why?
|
| Ipilimumab | 1 | 2019 | 61 | 0.150 |
Why?
|
| Myocardial Reperfusion | 1 | 2019 | 57 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 380 | 0.140 |
Why?
|
| Equipment Design | 1 | 2019 | 611 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2024 | 1700 | 0.140 |
Why?
|
| Defibrillators, Implantable | 1 | 2020 | 203 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 5399 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 154 | 0.130 |
Why?
|
| Research Report | 1 | 2017 | 71 | 0.130 |
Why?
|
| Coronary Angiography | 3 | 2023 | 486 | 0.130 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2019 | 120 | 0.130 |
Why?
|
| Acute Disease | 2 | 2024 | 1161 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2018 | 206 | 0.120 |
Why?
|
| Hospitalization | 3 | 2023 | 1891 | 0.120 |
Why?
|
| Pandemics | 2 | 2021 | 1187 | 0.120 |
Why?
|
| Risk Factors | 7 | 2025 | 10902 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 547 | 0.110 |
Why?
|
| Endocarditis, Bacterial | 1 | 2016 | 137 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 210 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2017 | 418 | 0.110 |
Why?
|
| Pulmonary Artery | 3 | 2023 | 463 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2025 | 3714 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2019 | 748 | 0.100 |
Why?
|
| Adult | 8 | 2021 | 31557 | 0.100 |
Why?
|
| Telemedicine | 1 | 2020 | 506 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2022 | 2494 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2013 | 175 | 0.090 |
Why?
|
| Catheters | 2 | 2023 | 89 | 0.090 |
Why?
|
| United States | 5 | 2024 | 11627 | 0.080 |
Why?
|
| Prevalence | 2 | 2025 | 2659 | 0.070 |
Why?
|
| Comorbidity | 2 | 2025 | 1606 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 2059 | 0.070 |
Why?
|
| Time Factors | 3 | 2025 | 6445 | 0.070 |
Why?
|
| Heart | 2 | 2023 | 699 | 0.070 |
Why?
|
| Photoplethysmography | 1 | 2025 | 7 | 0.060 |
Why?
|
| Global Health | 2 | 2020 | 616 | 0.060 |
Why?
|
| Extremities | 1 | 2024 | 86 | 0.050 |
Why?
|
| Biomarkers | 1 | 2013 | 3380 | 0.050 |
Why?
|
| Inpatients | 2 | 2020 | 553 | 0.050 |
Why?
|
| Lactates | 1 | 2023 | 86 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2025 | 214 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2025 | 535 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 289 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2022 | 198 | 0.050 |
Why?
|
| Denmark | 1 | 2021 | 29 | 0.040 |
Why?
|
| Weaning | 1 | 2021 | 49 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2025 | 6530 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2024 | 670 | 0.040 |
Why?
|
| Survivors | 1 | 2023 | 358 | 0.040 |
Why?
|
| Blood Volume | 1 | 2021 | 81 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 778 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2024 | 518 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2025 | 993 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2024 | 612 | 0.040 |
Why?
|
| Thrombosis | 1 | 2024 | 530 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5150 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 891 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 119 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2020 | 387 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 175 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2019 | 130 | 0.030 |
Why?
|
| Critical Care | 1 | 2023 | 686 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2022 | 784 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3083 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2227 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 7119 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 462 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3021 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 827 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2016 | 106 | 0.030 |
Why?
|
| Phenotype | 1 | 2025 | 4541 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 9940 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1454 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1451 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1255 | 0.020 |
Why?
|
| Obesity | 1 | 2024 | 2396 | 0.020 |
Why?
|
| Echocardiography | 1 | 2016 | 1125 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 2152 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 803 | 0.020 |
Why?
|
| Hypertension | 1 | 2017 | 1388 | 0.020 |
Why?
|
HERNANDEZ-MONTFORT's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_